FDA gets power to set infant formula safety limits—but enforcement details unclear
H.R. 9788 — FORMULA Act of 2026 · Filed by Brian Mast (R-FL) · 5 cosponsors · Introduced Jul 20, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the FDA to set legal limits on contaminants (heavy metals, microplastics, pesticides, and other harmful substances) in infant formula, and to enforce those limits through testing and record-keeping requirements on manufacturers. Manufacturers must test their products, keep records for at least two years, and the FDA must report annually to Congress on violations and contaminant levels found.
Why we flagged it
The bill's operative mechanism is the establishment and enforcement of contaminant limits in infant formula—a direct regulatory safety measure protecting a vulnerable population. The acronym (FORMULA Act) is a playful framing device but does not obscure the bill's actual function.
What the text implies
- The 180-day implementation timeline may create a compliance cliff for smaller manufacturers with limited testing infrastructure, potentially consolidating market share toward larger producers with existing quality-assurance systems.
- Annual congressional reporting of specific contaminant concentrations and manufacturer violations creates a public accountability mechanism that may drive market pressure on non-compliant brands independent of regulatory enforcement.
The full analysis lists 4 implications of this text.
Who stands to gain
infant formula manufacturers with existing quality-control and testing infrastructure; laboratory testing and analytical services providers; water treatment and source-water management companies